Thyroid FNAC Report: Bethesda Categories 1 to 6 Explained
A thyroid FNAC report places the sample into one of six Bethesda categories, from non-diagnostic to malignant. Read the category number and the next step printed beside it first, because the rest of the printout explains those two lines.
At a glance
- The test: a fine needle collects cells from a thyroid nodule, and the lab sorts them using the Bethesda System.
- Categories: six, from I (non-diagnostic) to VI (malignant). The 2023 edition kept the six categories and gave each one a single name.
- Next steps: the table below uses the 2017 edition’s management table, so check the plan your thyroid team gives you.
- Rule of thumb: a non-diagnostic sample means the needle did not gather enough usable cells, so the test is repeated, not that cancer was found.
Prefer to listen? This post as a 4 min video · Watch the video
What is an FNAC of the thyroid?
FNAC stands for fine needle aspiration cytology. A thin needle collects cells from a thyroid nodule, and a cytologist examines them under a microscope. The result is a category rather than a single word such as cancer or normal, and the category tells the thyroid team what the next step should be.
What do the six Bethesda categories mean?
The 2023 Bethesda System gives each of the six diagnostic categories one name. The table pairs each category with a plain meaning and with the usual next step from the 2017 management table.
| Category | Name | Plain meaning | Usual next step (2017 table) |
|---|---|---|---|
| I | Non-diagnostic | Too few usable cells to read | Repeat FNA with ultrasound guidance |
| II | Benign | Cells look non-cancerous | Clinical and sonographic follow-up |
| III | Atypia of undetermined significance | Some cells look unusual, but not clearly cancer | Repeat FNA, molecular testing or lobectomy |
| IV | Follicular neoplasm | A follicular-pattern growth that needs more tests | Molecular testing or lobectomy |
| V | Suspicious for malignancy | Cells raise a clear concern for cancer | Near-total thyroidectomy or lobectomy |
| VI | Malignant | Cells show cancer | Near-total thyroidectomy or lobectomy |
The next-step column comes from the 2017 edition’s table, as printed in a single-institution study. The 2023 edition updated the risk estimates for each category, so treat this table as a starting point and confirm the plan with your thyroid team.
Why does a non-diagnostic result happen?
A non-diagnostic result means the sample did not have enough usable cells for the cytologist to read. The 2017 table sends that category back for a repeat needle sample under ultrasound guidance. That is a request for another sample, not a verdict on the nodule. Ask whether your first sample was taken with ultrasound guidance, because the table names that approach for the repeat.
Why do categories III and IV need more tests?
Categories III and IV sit in the middle, where the cell pattern is not clear enough to call. The 2017 table lists molecular testing for both, and a repeat needle sample is also an option for category III. The 2023 edition added a new chapter on molecular and ancillary testing in thyroid cytopathology. The point of the extra step is to narrow the question, not to add alarm.
What does a benign result mean for follow-up?
Category II is the one that reads as non-cancerous, and the 2017 table’s next step is clinical and sonographic follow-up. In plain terms, the thyroid team keeps checking the nodule with examination and ultrasound. A benign label is not a guarantee, so keep the follow-up dates the clinic gives you.
Read two lines first
Look for the category number and the next step on the report before anything else. If the category is I, write down the date the repeat is due and confirm it with the clinic, since local practice varies.
What should you ask the thyroid clinic?
- Which category am I in? Ask for the category number and its name, and whether the lab used the 2017 or the 2023 edition.
- Was the sample guided? Ask whether ultrasound guided the needle, especially if the first result was non-diagnostic.
- When is the next step? Ask for the date of any repeat FNA, molecular test or scan, and who will follow the result.
- Will the nodule be measured again? Ask whether it will be re-measured at the same visit, and compare with any earlier ultrasound report.
The ultrasound side of the story, including the scoring words on the scan, is explained in the thyroid ultrasound TI-RADS guide. Thyroid hormone numbers are covered in the TSH normal range guide, and antibody results in the anti-TPO report guide. A borderline hormone reading has its own page in the borderline TSH guide. The other lab reports are in the Lab Reports Decoded hub.
Do not stop or change thyroid medicine because of a cytology result; the endocrine team decides. Contact the clinic promptly if a neck lump grows quickly, if swallowing or breathing becomes difficult, or if your voice changes and does not recover. If you are pregnant or breastfeeding, tell the team before the plan is set.
Thyroid FNAC questions, answered
What does a thyroid FNAC report mean?
It is a cell-sample report that places your nodule into one of six Bethesda categories, from non-diagnostic to malignant. The category number and the next step are the parts to read first.
What is Bethesda category 2 in the thyroid?
Category II means benign: the cells look non-cancerous, and the usual next step is clinical and ultrasound follow-up.
Is a non-diagnostic FNAC result bad news?
Not on its own. It means the sample lacked enough usable cells, and the 2017 table calls for a repeat FNA with ultrasound guidance.
What does Bethesda 3 in the thyroid mean, and what happens next?
Category III means atypia of undetermined significance. The next step is a repeat FNA, molecular testing or lobectomy, chosen with your thyroid team.
Does a benign thyroid FNAC mean there is no cancer?
No result is a guarantee. The safeguard for a category II result is the clinical and ultrasound follow-up the clinic schedules, so keep those appointments.
Do I need the risk percentage printed on my report?
You do not need it to read the report well. Ask the lab whether a risk figure is printed, and read the category name and next step first.
Why is molecular testing sometimes added?
The 2017 table lists molecular testing for categories III and IV, where the cell pattern alone may not settle the question. It is a way of narrowing the decision.
What does Bethesda 6 malignant mean?
Category VI means the cells show cancer. The 2017 table’s usual step is near-total thyroidectomy or lobectomy, and the surgical plan is set by your team.